June 13-17: Who said What in Biotech and Pharmaceutical Industries?


These are some fresh promises that researchers and scientists made regarding their innovation and research and the collaborators filled us with the hope to take their business to a higher level and benefit the human race;

Quote 1.

While blood sugar control is critical in diabetes, even more important is reducing the complications, and arguably the most important is in cardiovascular outcomes. We are not only looking at the cardiovascular safety requirement for regulatory approval, we expect to further define the benefit of ertugliflozin to deliver the reduction of cardiovascular complications and death”-Who said it? Answer is here

Quote 2.

These studies reflect Sanofi’s commitment to innovative approaches in developing medicines intended to help patients meet their needs throughout their diabetes journey”-Who said it? Answer is here

Quote 3.

Relapsed or refractory ALL is an aggressive leukemia in urgent need of new treatment options as about half of adult patients will not respond to chemotherapy or will see their disease return. The efficacy results seen in patients treated with inotuzumab ozogamicin in this study are impressive, particularly median progression-free survival, high rates of haematological remission and absence of minimal residual disease. These results suggest inotuzumab ozogamicin, if approved, could be a valuable new addition to currently available treatment options for ALL patients, including as a bridge to stem cell transplantation, which is the best chance for a cure at this stage of the disease”-Who said it? Answer is here

Quote 4.

Receiving Breakthrough Therapy Designation on two pipeline products this past week reflects the potential of our strong and innovative pipeline of more than 60 programs”-Who said it? Answer is here

Quote 5.

GONITRO™ is the first new dosage form in the short-acting nitrate category in nearly 20 years and we intend to educate healthcare providers and patients about our exciting new product immediately”-Who said it? Answer is here

Quote 6.

“QIDP facilitates getting a potentially life-saving new antibiotic to patients in the USA.  The FDA is not alone in recognizing that Gram-negative antibiotic resistance is a growing and a widespread epidemic, somewhat analogous to the situation with MRSA [methicillin-resistant Staphylococcus aureus] during the last decade”-Who said it? Answer is here

Quote 7.

With a child dying from malaria every two minutes and the threat of drug resistance growing year-on-year, there is a real urgency to step up global efforts to combat this disease. Partnerships and collaborations like this one with MMV are essential for the development of next generation antimalarial and accelerating efforts to eradicate this deadly disease”-Who said it? Answer is here

Quote 8.

Patients require frequent monitoring by a health care provider to shorten the tube as they lose weight and abdominal girth, so that the disk remains flush against their skin. Frequent medical visits are also necessary to monitor device use and weight loss and to provide counseling on lifestyle therapies”-Who said it? Answer is here


Leave a reply

Your email address will not be published. Required fields are marked *